Explainer
Colorectal cancer explained, including the rise in younger adults
Colorectal cancer is the second leading cause of US cancer death; SEER publishes American Cancer Society projections of about 158,850 new cases and 55,230 deaths in 2026.[1] Overall incidence is falling, but the American Cancer Society reports it rising 3% a year at ages 20 to 49, and colorectal cancer is now the leading cause of cancer death in US adults under 50.[2][3] The USPSTF recommends screening for adults aged 45 to 75, with stool tests, colonoscopy and other options.[4][5]
This page is general information, not medical advice. See a doctor about blood in your stool or a lasting change in bowel habits at any age; talk to a clinician about when and how to screen.
Colorectal cancer starts in the colon or rectum. The colon is the main part of the large intestine, about 5 feet long, and the rectum and anal canal make up its last part.[6] SEER publishes American Cancer Society projections of about 158,850 new US cases and 55,230 deaths in 2026. It is the fourth most commonly diagnosed cancer and the second leading cause of US cancer death.[1]
Rising in younger adults
Overall US incidence has been falling, about 0.5% a year over 2014-2023. Death rates fell about 1.3% a year over 2015-2024.[2] Younger adults are the exception. The American Cancer Society’s Colorectal cancer statistics, 2026 report says incidence is rising 3% a year at ages 20 to 49. Colorectal cancer is now the leading cause of cancer death in US adults under 50.[3] The USPSTF‘s May 2021 recommendation covers adults aged 45 to 49 (grade B) as well as 50 to 75 (grade A).[4]
Survival and stage
SEER reports 5-year relative survival, based on 2016–2022 data, of 65.4% overall. About 34% of cases are found while still localized, when survival is 91.3%. Survival falls to 16.9% once the cancer has spread to distant organs.[7] About 3.9% of people will be diagnosed with colorectal cancer during their lifetime.[2]
Risk factors
NCI’s list of risk factors includes:[8]
- a parent, sibling or child with colon or rectal cancer
- a personal history of high-risk adenomas (polyps 1 cm or larger, or with abnormal-looking cells)
- inherited conditions such as familial adenomatous polyposis (FAP) or Lynch syndrome
- ulcerative colitis or Crohn disease for 8 years or more
- three or more alcoholic drinks a day, smoking and obesity
- older age
NCI says obesity is linked to at least 13 types of cancer, and wider prevention evidence is collected in cancer prevention explained.[9]
Warning signs
NCI lists blood in the stool (bright red or very dark), a change in bowel habits, stools narrower than usual, abdominal discomfort, unexplained weight loss and fatigue. Other conditions can cause the same signs.[10] NCI notes that cancer often does not cause pain, so people should not wait for pain before seeing a doctor.[11]
Screening options
The USPSTF accepts several screening strategies:[5]
| Test | Interval (USPSTF) |
|---|---|
| FIT or high-sensitivity guaiac stool test | Every year |
| Stool DNA-FIT | Every 1 to 3 years |
| CT colonography or flexible sigmoidoscopy | Every 5 years |
| Colonoscopy | Every 10 years |
An abnormal stool test needs a follow-up colonoscopy.[12] The 2021 recommendation does not include blood tests, because the evidence for them was limited at the time.[13] The FDA has since approved the Shield blood test for colorectal cancer screening in average-risk adults 45 and older. Shield’s labelling says it has limited detection of stage I cancer, and a positive result should be followed by colonoscopy.[14] In England, the NHS sends a home FIT kit every two years to people aged 50 to 74.[15] Our buyer’s guide to at-home tests compares stool and blood options. The cancer screening explainer covers screening across cancers.
More in this series: lung cancer, breast cancer, prostate cancer and skin cancer. For other health topics, see the health crash course.
Read next
US Preventive Services Task Force (USPSTF)
The USPSTF sets the US cancer screening recommendations that shape free coverage. How it grades evidence, what it recommends, and its 2026 overhaul.
Questions readers ask
When should colorectal cancer screening start?
The USPSTF recommends screening for adults aged 45 to 75 (grade B at 45 to 49, grade A at 50 to 75). The NHS in England sends a home test kit every two years at 50 to 74.[4][15]
Is colorectal cancer rising in young people?
The American Cancer Society's 2026 report says incidence is rising 3% a year at ages 20 to 49 and that colorectal cancer is the leading cause of cancer death in US adults under 50, even though overall incidence is falling about 0.5% a year.[3][2]
What are the warning signs of colorectal cancer?
NCI lists blood in the stool (bright red or very dark), a change in bowel habits, stools narrower than usual, abdominal discomfort, unexplained weight loss and fatigue. Other conditions can cause the same signs.[10]
Do I need a colonoscopy, or is a stool test enough?
The USPSTF accepts several strategies, including a yearly FIT stool test, stool DNA-FIT every 1 to 3 years, CT colonography or flexible sigmoidoscopy every 5 years, or colonoscopy every 10 years. Any abnormal stool test needs a follow-up colonoscopy.[5][12]
Who is at higher risk?
NCI lists a parent, sibling or child with colorectal cancer, a history of high-risk polyps, inherited conditions such as Lynch syndrome and familial adenomatous polyposis, long-standing ulcerative colitis or Crohn disease, heavy drinking, smoking and obesity, as well as older age.[8]
Sources
· 15 claims from 7 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
SEER publishes ACS projections of about 158,850 new US colorectal cancer cases and 55,230 deaths in 2026; it is the fourth most commonly diagnosed cancer and the second leading cause of US cancer death. confirmedas of 2026-11-07
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Statistics at a glance (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Did you know? (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Deaths (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Statistics at a glance (note) (retrieved 2026-11-07)
- [2]
SEER reports overall US colorectal cancer incidence falling about 0.5% a year over 2014-2023 and death rates falling about 1.3% a year over 2015-2024; about 3.9% of people will be diagnosed in their lifetime. confirmedas of 2026-11-07
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Trends (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Trends (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Lifetime risk (retrieved 2026-11-07)
- [3]
The American Cancer Society's Colorectal cancer statistics, 2026 report says colorectal cancer is the leading cause of cancer death in US adults under 50, with incidence rising 3% a year at ages 20 to 49, and calls for educating clinicians and the public about its symptoms. confirmedas of 2026-10-11
- Colorectal cancer statistics, 2026 · CA: A Cancer Journal for Clinicians (American Cancer Society) · Primary source · 2026-03-01 · Abstract (retrieved 2026-10-11)
- Colorectal cancer statistics, 2026 · CA: A Cancer Journal for Clinicians (American Cancer Society) · Primary source · 2026-03-01 · Abstract (retrieved 2026-10-11)
- Colorectal cancer statistics, 2026 · CA: A Cancer Journal for Clinicians (American Cancer Society) · Primary source · 2026-03-01 · Abstract (retrieved 2026-10-11)
- [4]
The USPSTF (May 2021) recommends colorectal cancer screening for all adults aged 50 to 75 (grade A) and adults aged 45 to 49 (grade B), and selective screening at 76 to 85 (grade C). confirmedas of 2026-10-11
- Colorectal Cancer: Screening (final recommendation statement, May 18, 2021) · US Preventive Services Task Force · Primary source · 2021-05-18 · Recommendation Summary (retrieved 2026-10-11)
- Colorectal Cancer: Screening (final recommendation statement, May 18, 2021) · US Preventive Services Task Force · Primary source · 2021-05-18 · Recommendation Summary (retrieved 2026-10-11)
- Colorectal Cancer: Screening (final recommendation statement, May 18, 2021) · US Preventive Services Task Force · Primary source · 2021-05-18 · Clinician Summary (retrieved 2026-10-11)
- [5]
The USPSTF's recommended colorectal screening strategies include FIT or high-sensitivity guaiac stool testing every year, stool DNA-FIT every 1 to 3 years, CT colonography or flexible sigmoidoscopy every 5 years, and colonoscopy every 10 years. confirmedas of 2026-10-11
- Colorectal Cancer: Screening (final recommendation statement, May 18, 2021) · US Preventive Services Task Force · Primary source · 2021-05-18 · Clinician Summary (retrieved 2026-10-11)
- [6]
The colon is the main part of the large intestine, about 5 feet long; the rectum and anal canal make up its last part. confirmedas of 2026-11-07
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · General information (retrieved 2026-11-07)
- [7]
SEER reports 5-year relative survival, based on SEER 21 data for 2016-2022, for colorectal cancer of 65.4% overall, 91.3% when localized and 16.9% when distant; 34% of cases are found at the localized stage. confirmedas of 2026-11-07
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Survival chart caption; the full range printed is 2016-2022 (en dash rendered as an HTML entity) (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Statistics at a glance (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Survival by stage (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Survival by stage table (retrieved 2026-11-07)
- Cancer Stat Facts: Colorectal Cancer · National Cancer Institute SEER Program · Primary source · Survival by stage (retrieved 2026-11-07)
- [8]
NCI's colorectal cancer risk factors include a first-degree relative with colorectal cancer, a personal history of high-risk adenomas (polyps), inherited syndromes such as familial adenomatous polyposis and Lynch syndrome, ulcerative colitis or Crohn disease for 8 years or more, three or more alcoholic drinks a day, smoking and obesity, plus older age. confirmedas of 2026-11-07
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Risk factors (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Risk factors (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Risk factors (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Risk factors (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Risk factors (retrieved 2026-11-07)
- [9]
NCI says obesity is linked to at least 13 types of cancer. confirmedas of 2026-10-11
- Obesity and Cancer (fact sheet) · National Cancer Institute · Primary source · What is obesity? (retrieved 2026-10-11)
- [10]
Signs of colon cancer include blood in the stool (bright red or very dark), a change in bowel habits, stools narrower than usual, abdominal discomfort, unexplained weight loss and fatigue; other conditions can cause the same signs. confirmedas of 2026-11-07
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Signs and symptoms (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Signs and symptoms (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Signs and symptoms (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Signs and symptoms (retrieved 2026-11-07)
- Colon Cancer Treatment (PDQ) - Patient Version · National Cancer Institute · Primary source · Signs and symptoms (retrieved 2026-11-07)
- [11]
NCI notes that cancer often does not cause pain, so people should not wait for pain before seeing a doctor. confirmedas of 2026-10-11
- Symptoms of Cancer · National Cancer Institute · Primary source · Paragraph 1 (retrieved 2026-10-11)
- [12]
Under the USPSTF recommendation, an abnormal stool-based test result needs follow-up colonoscopy. confirmedas of 2026-10-11
- Colorectal Cancer: Screening (final recommendation statement, May 18, 2021) · US Preventive Services Task Force · Primary source · 2021-05-18 · Practice Considerations (retrieved 2026-10-11)
- [13]
The 2021 USPSTF colorectal recommendation does not include blood (serum) tests, urine tests or capsule endoscopy because of limited evidence. confirmedas of 2026-10-11
- Colorectal Cancer: Screening (final recommendation statement, May 18, 2021) · US Preventive Services Task Force · Primary source · 2021-05-18 · Recommendation rationale (retrieved 2026-10-11)
- [14]
Shield is FDA-approved for colorectal cancer screening in average-risk adults 45 and older; positive results should be followed by colonoscopy, its labelling says it has limited detection (55% to 65%) of stage I cancer and does not detect 87% of precancerous lesions, and it is not indicated for people at high risk, such as those with inflammatory bowel disease or a family history of colorectal cancer. confirmedas of 2026-10-11
- Shield Blood Test (product site, important product information and cost) · Guardant Health · Primary source · Intended Use (retrieved 2026-10-11)
- Shield Blood Test (product site, important product information and cost) · Guardant Health · Primary source · Precaution (retrieved 2026-10-11)
- Shield Blood Test (product site, important product information and cost) · Guardant Health · Primary source · Limitations and Other Important Information (retrieved 2026-10-11)
- Colorectal cancer: FDA-approved 2nd blood test can close screening gap · Medical News Today · Secondary source · 2026-07-29 · Body (retrieved 2026-10-11)
- [15]
In England the NHS offers cervical screening every 5 years at ages 25 to 64, breast screening at 50 to 70 (self-referral over 70), and a home bowel test kit every 2 years at 50 to 74. confirmedas of 2026-10-11
- NHS screening · NHS · Primary source · Cervical screening (retrieved 2026-10-11)
- NHS screening · NHS · Primary source · Breast screening (retrieved 2026-10-11)
- NHS screening · NHS · Primary source · Bowel cancer screening (retrieved 2026-10-11)
Revision history (2)
- Stated that SEER survival figures are based on 2016–2022 data.
- Page created.
Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.
Cite this page
"Colorectal cancer explained, including the rise in younger adults." ContentLora, updated Nov 14, 2026. https://contentlora.com/explain/colorectal-cancer-explained
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.